Select Page

CJD

 | Click to Receive Email Notifications of Posts
Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
    Posts
  • #70447
    SAWMH.ICC
    Participant

    Author:
    SAWMH.ICC

    Email:
    SAWMH.ICC@UCHEALTH.COM.AU

    Organisation:

    State:

    Good morning Everyone,

    We are currently reviewing our Risk assessment tool. We have added Infection Control questions, these include risks for MRO’s, wounds / devices and cCJD.
    We don’t have enough space to add all the infection control risks . We have a few questions on CJD but I was hoping to reduce the number to only 2 questions.
    Can anyone please share with me, your questions on the risk for CJD?

    Thank you

    Marlize Senekal
    Infection Prevention and Control Coordinator
    St. Andrew’s War Memorial Hospital
    457 Wickham Terrace, Spring Hill
    Brisbane
    Ph. 07-3834 4444
    Ext. 4328, Pg. 0328

    Uniting Care Health Email Disclaimer: http://www.uchealth.com.au/disclaimer

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70450
    Michele.Cullen@HEALTH.VIC.GOV.AU Subject: Re: CJD In-Reply-To:
    Participant

    Author:
    Michele.Cullen@HEALTH.VIC.GOV.AU Subject: Re: CJD In-Reply-To:

    Organisation:

    State:

    Dear Marlize

    The CJD guidelines questions should be asked by the treating medical
    officer. They should form part of the decision making related to the need
    for surgery, as part of the diagnostic work-up, and any surgical
    arrangements.
    They should only be asked if the patient is having high risk tissue surgery
    and is either low risk or high risk for CJD.

    Please refer to:
    Table 1 on page 4 Known or predicted infectivity of human body tissues
    and fluids for CJD
    Section 2.3 Patient risk categories on page 5
    Section 2.4 Risk assessment on page 5 – Table 2
    Appendix 3 Risk assessment tool on page 19
    Appendix 4 summary of actions for a surgical procedure on page 21.

    Together they help the treating medical officer to decide if:
    this is a background/low/high risk patient
    the procedure involves high-medium or low-no infectivity tissue
    the reprocessing required, that is, routine or additional procedures
    (Table 2)

    Therefore, there is no need for all patients being admitted to a health
    care facility to be routinely asked questions about CJD when they are not
    in any of the above situations, particularly when you frequently have to
    explain what it is.

    NBWe now refer to CJD as CJD and not cCJD – the term classical has been
    dropped internationally. That is, it is CJD (in its various forms) and
    vCJD.

    I am a member of the CDNA writing group which revised the current
    guidelines which are not very different to the 2007 version. There is some
    clarification and additional detail in some sections but the basic premise
    is the same.

    I would be happy for you to contact me off line if you wish.

    Regards

    (Embedded (Embedded image moved to file: pic27048.jpg)
    image moved
    to file:
    pic30484.jpg)

    Michele Cullen
    Infection Control Consultant | Communicable Disease Prevention and
    Control | Public Health
    Department of Health | 50 Lonsdale Street, Melbourne, Victoria,
    3000
    p. 03 9096 5094 | f. 1300 651 170
    e. michele.cullen@health.vic.gov.au

    |————>
    | From: |
    |————>
    >————————————————————————————————————————————————–|
    |”SAWMH.ICC” |
    >————————————————————————————————————————————————–|
    |————>
    | To: |
    |————>
    >————————————————————————————————————————————————–|
    |AICALIST@AICALIST.ORG.AU |
    >————————————————————————————————————————————————–|
    |————>
    | Date: |
    |————>
    >————————————————————————————————————————————————–|
    |05/09/2013 07:23 AM |
    >————————————————————————————————————————————————–|
    |————>
    | Subject: |
    |————>
    >————————————————————————————————————————————————–|
    |CJD |
    >————————————————————————————————————————————————–|
    |————>
    | Sent by: |
    |————>
    >————————————————————————————————————————————————–|
    |ACIPC Infexion Connexion |
    >————————————————————————————————————————————————–|

    Good morning Everyone,

    We are currently reviewing our Risk assessment tool. We have added
    Infection Control questions, these include risks for MRO’s, wounds /
    devices and cCJD.
    We don’t have enough space to add all the infection control risks . We have
    a few questions on CJD but I was hoping to reduce the number to only 2
    questions.
    Can anyone please share with me, your questions on the risk for CJD?

    Thank you

    Marlize Senekal
    Infection Prevention and Control Coordinator
    St. Andrew’s War Memorial Hospital
    457 Wickham Terrace, Spring Hill
    Brisbane
    Ph. 07-3834 4444
    Ext. 4328, Pg. 0328

    Uniting Care Health Email Disclaimer: http://www.uchealth.com.au/disclaimer
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO
    NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is
    discouraged by ACIPC. If you wish to discuss specific reference to products
    or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives
    registration and login required.

    Replies to this message will be directed back to the list. To create a new
    message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to
    aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without
    the quotes) to listserv@aicalist.org.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70449
    Michael Wishart
    Participant

    Author:
    Michael Wishart

    Email:
    Michael.Wishart@hsn.org.au

    Organisation:

    State:

    Hi Marlize

    This is a bit tricky, as you need to be able to identify all of the risks for CJD when asking these questions. Also confounding is the fact that the questions recommended for assessment of CJD risk in Appendix 13 of the January 2013 CJD document from the CJD ICG Working Group (http://www.health.gov.au/internet/main/publishing.nsf/content/AC9448D36D359F50CA2577C40016F0F6/$File/CJDInfectionControlGuidelinesJan2013.pdf) are recommended to be asked of the treating medical officer, not the patient. We have managed to reduce the questions to only 5 on our pre-admission assessment, and they relate to the following risks:

    – Patient or two or more family members with history of CJD

    – Received human pituitary hormone prior to 1985

    – Received dura mater graft prior to 1986

    – Recent undiagnosed rapid progressive dementia

    – Involved in a ‘lookback’ for CJD exposure

    We tried to reduce these questions even more, but we felt we would miss out on some risks if we did not ask explicitly. The trick is to word the questions in a way most patients will understand.

    Another option is to include a very simple CJD risk assessment for all patients, and then a more comprehensive assessment for those undergoing vat-risk procedures (defined in the guidelines as: ‘eg neurosurgery, spinal cord surgery, ophthalmic surgery, pituitary surgery’). The major difficulty for this is when is this assessment done and by whom, ensuring you do not miss any eligible patients.

    Hope these thoughts help.

    Cheers
    Michael

    Michael Wishart
    CNC Infection Control
    Holy Spirit Northside Private Hospital
    627 Rode Road, Chermside, Qld 4032
    t: (07) 3326 3068 | f: (07) 3607 2226
    e: Michael.Wishart@hsn.org.au
    w:www.holyspiritnorthside.org.au
    Please consider the environment before printing this email

    Good morning Everyone,

    We are currently reviewing our Risk assessment tool. We have added Infection Control questions, these include risks for MRO’s, wounds / devices and cCJD.
    We don’t have enough space to add all the infection control risks . We have a few questions on CJD but I was hoping to reduce the number to only 2 questions.
    Can anyone please share with me, your questions on the risk for CJD?

    Thank you

    Marlize Senekal
    Infection Prevention and Control Coordinator
    St. Andrew’s War Memorial Hospital
    457 Wickham Terrace, Spring Hill
    Brisbane
    Ph. 07-3834 4444
    Ext. 4328, Pg. 0328

    Uniting Care Health Email Disclaimer: http://www.uchealth.com.au/disclaimer
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    ________________________________
    Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.
    http://www.mailguard.com.au

    Report this message as spam


    WARNING : This email contains information, which is CONFIDENTIAL, and that maybe subject to LEGAL PRIVILEGE. This e-mail and any attachments to it (the “Communication”) is confidential and is for the use only of the intended recipient, and may not duplicated or used by any other party without the express consent of the sender. The Communication may contain copyright material of St Vincent’s Health & Aged Care(“SVHAC”), or any of its related entities or of third parties. If you are not the intended recipient of the Communication, please notify the sender immediately by return e-mail, delete the Communication, and do not read, copy, print, retransmit, store or act in reliance on the Communication. Any views expressed in the Communication are those of the individual sender only, unless expressly stated to be those of SVHAC. SVHAC does not guarantee the integrity of the Communication, or that it is free from errors, viruses or interference. Thank-you.

    Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.
    http://www.mailguard.com.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    #70451
    SAWMH.ICC
    Participant

    Author:
    SAWMH.ICC

    Email:
    SAWMH.ICC@UCHEALTH.COM.AU

    Organisation:

    State:

    Thank you to Everyone who have responded to my question on CJD.

    We are currently using the questions below, but like I’ve mentioned, it gets tricky when you don’t have much space to work with and you need to ask all of these.

    Best wishes

    Marlize Senekal
    Infection Prevention and Control Coordinator
    St. Andrew’s War Memorial Hospital
    457 Wickham Terrace, Spring Hill
    Brisbane
    Ph. 07-3834 4444
    Ext. 4328, Pg. 0328

    ________________________________

    Hi Marlize

    This is a bit tricky, as you need to be able to identify all of the risks for CJD when asking these questions. Also confounding is the fact that the questions recommended for assessment of CJD risk in Appendix 13 of the January 2013 CJD document from the CJD ICG Working Group (http://www.health.gov.au/internet/main/publishing.nsf/content/AC9448D36D359F50CA2577C40016F0F6/$File/CJDInfectionControlGuidelinesJan2013.pdf) are recommended to be asked of the treating medical officer, not the patient. We have managed to reduce the questions to only 5 on our pre-admission assessment, and they relate to the following risks:

    – Patient or two or more family members with history of CJD

    – Received human pituitary hormone prior to 1985

    – Received dura mater graft prior to 1986

    – Recent undiagnosed rapid progressive dementia

    – Involved in a ‘lookback’ for CJD exposure

    We tried to reduce these questions even more, but we felt we would miss out on some risks if we did not ask explicitly. The trick is to word the questions in a way most patients will understand.

    Another option is to include a very simple CJD risk assessment for all patients, and then a more comprehensive assessment for those undergoing vat-risk procedures (defined in the guidelines as: ‘eg neurosurgery, spinal cord surgery, ophthalmic surgery, pituitary surgery’). The major difficulty for this is when is this assessment done and by whom, ensuring you do not miss any eligible patients.

    Hope these thoughts help.

    Cheers
    Michael

    Michael Wishart
    CNC Infection Control
    Holy Spirit Northside Private Hospital
    627 Rode Road, Chermside, Qld 4032
    t: (07) 3326 3068 | f: (07) 3607 2226
    e: Michael.Wishart@hsn.org.au
    w:www.holyspiritnorthside.org.au
    Please consider the environment before printing this email

    Good morning Everyone,

    We are currently reviewing our Risk assessment tool. We have added Infection Control questions, these include risks for MRO’s, wounds / devices and cCJD.
    We don’t have enough space to add all the infection control risks . We have a few questions on CJD but I was hoping to reduce the number to only 2 questions.
    Can anyone please share with me, your questions on the risk for CJD?

    Thank you

    Marlize Senekal
    Infection Prevention and Control Coordinator
    St. Andrew’s War Memorial Hospital
    457 Wickham Terrace, Spring Hill
    Brisbane
    Ph. 07-3834 4444
    Ext. 4328, Pg. 0328

    Uniting Care Health Email Disclaimer: http://www.uchealth.com.au/disclaimer
    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    ________________________________
    Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.
    http://www.mailguard.com.au

    Report this message as spam

    WARNING : This email contains information, which is CONFIDENTIAL, and that maybe subject to LEGAL PRIVILEGE. This e-mail and any attachments to it (the “Communication”) is confidential and is for the use only of the intended recipient, and may not duplicated or used by any other party without the express consent of the sender. The Communication may contain copyright material of St Vincent’s Health & Aged Care(“SVHAC”), or any of its related entities or of third parties. If you are not the intended recipient of the Communication, please notify the sender immediately by return e-mail, delete the Communication, and do not read, copy, print, retransmit, store or act in reliance on the Communication. Any views expressed in the Communication are those of the individual sender only, unless expressly stated to be those of SVHAC. SVHAC does not guarantee the integrity of the Communication, or that it is free from errors, viruses or interference. Thank-you.

    ________________________________
    Message protected by MailGuard: e-mail anti-virus, anti-spam and content filtering.
    http://www.mailguard.com.au

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

    Uniting Care Health Email Disclaimer: http://www.uchealth.com.au/disclaimer

    MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

    The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

    Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

    Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

    To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

    You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

Viewing 4 posts - 1 through 4 (of 4 total)
  • The forum ‘Infexion Connexion’ is closed to new topics and replies.